KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Non-cash Items (2018 - 2021)

Aquestive Therapeutics has reported Non-cash Items over the past 4 years, most recently at $6.7 million for Q1 2021.

  • For Q1 2021, Non-cash Items fell 22.88% year-over-year to $6.7 million; the TTM value through Mar 2021 reached $6.7 million, down 22.88%, while the annual FY2020 figure was $1.2 million, 205.69% up from the prior year.
  • Non-cash Items for Q1 2021 was $6.7 million at Aquestive Therapeutics, up from $1.2 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $8.7 million in Q1 2020 and troughed at $87000.0 in Q4 2018.
  • A 4-year average of $2.5 million and a median of $620000.0 in 2019 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: soared 5854.11% in 2020 and later fell 22.88% in 2021.
  • Year by year, Non-cash Items stood at $87000.0 in 2018, then surged by 364.37% to $404000.0 in 2019, then soared by 205.69% to $1.2 million in 2020, then soared by 442.83% to $6.7 million in 2021.
  • Business Quant data shows Non-cash Items for AQST at $6.7 million in Q1 2021, $1.2 million in Q4 2020, and $6.6 million in Q3 2020.